Open trial of recombinant Der f 2 pullulan-conjugated immunotherapy in cats

IF 1.9 3区农林科学 Q3 DERMATOLOGY

Veterinary dermatology Pub Date : 2023-12-11 DOI:10.1111/vde.13217

Franco Martini, Ana Rostaher, Claude Favrot, Nina M. Fischer

引用次数: 0

Abstract

Allermmune HDM (Zenoaq) is a recombinant Dermatophagoides farinae 2 (Der f 2) pullulan-based immunotherapy vaccine whose efficacy on house dust mite allergic dogs has been demonstrated. There is no published information on its use in cats.

Abstract Image

查看原文本刊更多论文

猫用重组 Der f 2 拉普兰结合免疫疗法的公开试验

Allermmune HDM (Zenoaq) 是一种基于重组 Dermatophagoides farinae 2 (Der f 2) 纤维素的免疫疗法疫苗，其对屋尘螨过敏犬的疗效已得到证实。目前还没有关于该疫苗用于猫的公开信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Veterinary dermatology 农林科学-兽医学

CiteScore

3.20

自引率

21.40%

发文量

审稿时长

12-24 weeks

期刊介绍： Veterinary Dermatology is a bi-monthly, peer-reviewed, international journal which publishes papers on all aspects of the skin of mammals, birds, reptiles, amphibians and fish. Scientific research papers, clinical case reports and reviews covering the following aspects of dermatology will be considered for publication: -Skin structure (anatomy, histology, ultrastructure) -Skin function (physiology, biochemistry, pharmacology, immunology, genetics) -Skin microbiology and parasitology -Dermatopathology -Pathogenesis, diagnosis and treatment of skin diseases -New disease entities